World's Best Scientists 2026 revealed!
Mark C. Poznansky

Mark C. Poznansky

D-Index & Metrics

Immunology

D-Index
49
Citations
13116
World Ranking
4304
National Ranking
1956

Overview

Mark C. Poznansky is affiliated with Harvard University in the United States. Their research spans multiple fields within medicine and biochemistry, genetics, and molecular biology.

Their work focuses heavily on infectious diseases and immunology, with significant contributions in molecular biology, oncology, and genetics. Key topics in their research include SARS-CoV-2 and COVID-19 studies, clinical research on COVID-19, vector-borne infectious diseases, viral infections and vectors, viral gastroenteritis research and epidemiology, cancer genomics and diagnostics, and pancreatic function and diabetes.

Frequent co-authors collaborating with Mark C. Poznansky include:

  • Ann E. Sluder
  • Patrick M. Reeves
  • A. John Iafrate
  • Vivek Naranbhai
  • Alejandro B. Balazs

Key venues for publication feature prominently in their academic career and include:

  • The FASEB Journal
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Cell
  • The Journal of Infectious Diseases

Representative recent papers authored or co-authored by Poznansky are:

  • Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity, 2021, Cell
  • mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant, 2022, Cell
  • Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity, 2021, Cell
  • Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity, 2021, bioRxiv (Cold Spring Harbor Laboratory)
  • Rethinking the role of hydroxychloroquine in the treatment of COVID-19, 2020, The FASEB Journal

The scholar's extensive publication record includes over 100 publications in medicine, with significant contributions to infectious diseases research, highlighting a focus on COVID-19 and related viral infections.

Best Publications

  • mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

    Unknown

  • Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.

    Wilfredo F. Garcia-Beltran;Wilfredo F. Garcia-Beltran;Evan C. Lam;Kerri St. Denis;Adam D. Nitido

  • Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy

    Yuhui Huang;Jianping Yuan;Elda Righi;Walid S. Kamoun

  • Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor

    Gregor B. Adams;Karissa T. Chabner;Ian R. Alley;Douglas P. Olson

  • Active movement of T cells away from a chemokine.

    Mark C. Poznansky;Ivona T. Olszak;Russell Foxall;Richard H. Evans

  • CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer

    Elda Righi;Satoshi Kashiwagi;Jianping Yuan;Michael Santosuosso

  • Erratum: Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity (Cell (2021) 184(9) (2372–2383.e9), (S0092867421002981), (10.1016/j.cell.2021.03.013))

    Wilfredo F. Garcia-Beltran;Wilfredo F. Garcia-Beltran;Evan C. Lam;Kerri St. Denis;Adam D. Nitido

  • Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector

    M Poznansky;A Lever;L Bergeron;W Haseltine

  • Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures.

    E. Langhoff;E. F. Terwilliger;H. J. Bos;K. H. Kalland

  • Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines

    Unknown

  • Extracellular calcium elicits a chemokinetic response from monocytes in vitro and in vivo

    Ivona T. Olszak;Mark C. Poznansky;Richard H. Evans;Douglas Olson

  • Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof

    Joseph G. Sodroski;William A. Haseltine;Mark Poznansky;Andrew Lever

  • Efficient generation of human T cells from a tissue-engineered thymic organoid

    Mark C. Poznansky;Richard H. Evans;Russell B. Foxall;Ivona T. Olszak

  • Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment.

    Yang Zeng;Binghao Li;Yingying Liang;Patrick M. Reeves

  • Rethinking the role of hydroxychloroquine in the treatment of COVID-19.

    Eric A. Meyerowitz;Augustin G. L. Vannier;Morgan G. N. Friesen;Sara Schoenfeld

  • Neutrophil chemorepulsion in defined interleukin‐8 gradients in vitro and in vivo

    William G. Tharp;R. Yadav;D. Irimia;A. Upadhyaya

  • Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital.

    Tyler E. Miller;Wilfredo F. Garcia Beltran;Adam Z. Bard;Tasos Gogakos

  • Thymocyte emigration is mediated by active movement away from stroma-derived factors

    Mark C. Poznansky;Ivona T. Olszak;Richard H. Evans;Zhengyu Wang

  • Murine B16 Melanomas Expressing High Levels of the Chemokine Stromal-Derived Factor-1/CXCL12 Induce Tumor-Specific T Cell Chemorepulsion and Escape from Immune Control

    Fabrizio Vianello;Natalia Papeta;Tao Chen;Paul Kraft

  • Alginate-microencapsulation of human stem cell-derived β cells with CXCL12 prolongs their survival and function in immunocompetent mice without systemic immunosuppression.

    David A Alagpulinsa;Jenny J L Cao;Jenny J L Cao;Riley K Driscoll;Riley K Driscoll;Ruxandra F Sîrbulescu

  • Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues, anti-IgE, and a histamine-releasing lymphokine.

    Barry Gruber;Mark Poznansky;Eleonore Boss;Jacqueline Partin

  • Resistance to Methylprednisolone in Cultures of Blood Mononuclear Cells from Glucocorticoid-Resistant Asthmatic Patients

    M. C. Poznansky;A. C. H. Gordon;J. G. Douglas;A. S. Krajewski

  • Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.

    Wilfredo F Garcia-Beltran;Wilfredo F Garcia-Beltran;Evan C Lam;Kerri St Denis;Adam D Nitido

Frequent Co-Authors

Jeffrey A. Gelfand
Jeffrey A. Gelfand Harvard University
David T. Scadden
David T. Scadden Harvard University
James F. Markmann
James F. Markmann Harvard University
Aaron G. Schmidt
Aaron G. Schmidt Ragon Institute of MGH, MIT and Harvard
John T. Potts
John T. Potts Harvard University
Vivek Naranbhai
Vivek Naranbhai Monash University
Richard Coker
Richard Coker London School of Hygiene & Tropical Medicine
A. John Iafrate
A. John Iafrate Harvard University
Daniel Irimia
Daniel Irimia Harvard University
Joseph Sodroski
Joseph Sodroski Harvard Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your expertise through related healthcare degrees can open diverse career opportunities. Nursing programs, particularly accelerated options, offer a practical route to apply immunological knowledge in clinical settings. Programs like the 12-month accelerated nursing programs online for non nurses allow students without prior nursing backgrounds to transition quickly into the profession, combining foundational sciences with patient care.

If you are seeking more accessible entry points, consider the absn programs with high acceptance rates. These programs provide a streamlined path to a Bachelor of Science in Nursing, often designed for career changers or recent graduates of other fields.

For those focused on practical nursing roles, the best easiest lpn programs to get into offer opportunities to enter the workforce quickly while gaining essential skills that complement immunology research and healthcare delivery.

Advanced practice is another area to consider. The easiest nurse practitioner degree programs provide avenues for nurses aiming to specialize further in immunology-related conditions and patient management in diverse healthcare environments.

Best Scientists Citing Mark C. Poznansky

Trending Scientists